178 related articles for article (PubMed ID: 38319348)
1. Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients.
Cai D; Chen Q; Mao L; Xiao T; Wang Y; Gu Q; Wang Q; Ji Y; Sun L
Eur J Clin Pharmacol; 2024 Apr; 80(4):613-620. PubMed ID: 38319348
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Dapagliflozin on contrast-induced acute kidney injury in patients with type 2 diabetes mellitus underwent percutaneous coronary intervention].
Yang SC; Ma YF; Zhang P; Cong HL; Fu NK
Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(22):2059-2065. PubMed ID: 38858216
[No Abstract] [Full Text] [Related]
3. [Effects of hemoglobin level on the risk of acute kidney injury in patients with acute myocardial infarction].
Sun L; Chi B; Mao L; Zou A; Wang Q; Jiang J; Ji Y; Zhou X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1243-1247. PubMed ID: 36567576
[TBL] [Abstract][Full Text] [Related]
4. Dapagliflozin reduces risk of heart failure rehospitalization in diabetic acute myocardial infarction patients: a propensity score-matched analysis.
Mao L; Cai D; Chi B; Xiao T; Zou A; Wang Y; Chen Q; Gu Q; Wang Q; Ji Y; Sun L
Eur J Clin Pharmacol; 2023 Jul; 79(7):915-926. PubMed ID: 37099214
[TBL] [Abstract][Full Text] [Related]
5. SGLT2 inhibitor dapagliflozin protects the kidney in a murine model of Balkan nephropathy.
Oe Y; Kim YC; Sidorenko VS; Zhang H; Kanoo S; Lopez N; Goodluck HA; Crespo-Masip M; Vallon V
Am J Physiol Renal Physiol; 2024 Feb; 326(2):F227-F240. PubMed ID: 38031729
[TBL] [Abstract][Full Text] [Related]
6. Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Zhu Y; Zhang JL; Yan XJ; Sun L; Ji Y; Wang FF
Cardiovasc Diabetol; 2022 Sep; 21(1):186. PubMed ID: 36114538
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.
Paolisso P; Bergamaschi L; Gragnano F; Gallinoro E; Cesaro A; Sardu C; Mileva N; Foà A; Armillotta M; Sansonetti A; Amicone S; Impellizzeri A; Esposito G; Morici N; Andrea OJ; Casella G; Mauro C; Vassilev D; Galie N; Santulli G; Marfella R; Calabrò P; Pizzi C; Barbato E
Pharmacol Res; 2023 Jan; 187():106597. PubMed ID: 36470546
[TBL] [Abstract][Full Text] [Related]
8. Transient inhibition of sodium-glucose cotransporter 2 after ischemia/reperfusion injury ameliorates chronic kidney disease.
Martínez-Rojas MÁ; Balcázar H; González-Soria I; González-Rivera JM; Rodríguez-Vergara ME; Velazquez-Villegas LA; León-Contreras JC; Pérez-Villalva R; Correa F; Rosetti F; Bobadilla NA
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38516890
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.
Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
PLoS One; 2018; 13(3):e0194152. PubMed ID: 29529072
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of dapagliflozin in improving arrhythmia-related outcomes after ablation for atrial fibrillation: a retrospective single-center study.
Noh HJ; Cha SJ; Kim CH; Choi SW; Lee CH; Hwang JK
Clin Res Cardiol; 2024 Jun; 113(6):924-932. PubMed ID: 38358416
[TBL] [Abstract][Full Text] [Related]
11. The effect of perioperative diuretic administration on acute kidney injury in patients with acute myocardial infarction after percutaneous coronary intervention: a real-world retrospective study.
Nong Y; Wei X; Lu J; Wu D; Yu D
Eur J Clin Pharmacol; 2023 Sep; 79(9):1205-1213. PubMed ID: 37393209
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact and predictors of persistent renal dysfunction in acute kidney injury after percutaneous coronary intervention for acute myocardial infarction.
Nakamura T; Watanabe M; Sugiura J; Kyodo A; Nobuta S; Nogi K; Nakada Y; Ishihara S; Hashimoto Y; Nakagawa H; Ueda T; Seno A; Nishida T; Onoue K; Hikoso S
Sci Rep; 2024 Mar; 14(1):6299. PubMed ID: 38491142
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil Percentage as a Potential Biomarker of Acute Kidney Injury Risk and Short-Term Prognosis in Patients with Acute Myocardial Infarction in the Elderly.
Chen Q; Gu Q; Yin A; Cai D; Xiao T; Wang Y; Ji Y; Wang Q; Wei J; Sun L
Clin Interv Aging; 2024; 19():503-515. PubMed ID: 38525316
[TBL] [Abstract][Full Text] [Related]
14. Association between triglyceride glucose and acute kidney injury in patients with acute myocardial infarction: a propensity score‑matched analysis.
Cai D; Xiao T; Chen Q; Gu Q; Wang Y; Ji Y; Sun L; Wei J; Wang Q
BMC Cardiovasc Disord; 2024 Apr; 24(1):216. PubMed ID: 38643093
[TBL] [Abstract][Full Text] [Related]
15. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry.
Paolisso P; Bergamaschi L; Cesaro A; Gallinoro E; Gragnano F; Sardu C; Mileva N; Foà A; Armillotta M; Sansonetti A; Amicone S; Impellizzeri A; Belmonte M; Esposito G; Morici N; Andrea Oreglia J; Casella G; Mauro C; Vassilev D; Galie N; Santulli G; Calabrò P; Barbato E; Marfella R; Pizzi C
Diabetes Res Clin Pract; 2023 Aug; 202():110766. PubMed ID: 37276980
[TBL] [Abstract][Full Text] [Related]
16. Effect of Renin-Angiotensin System Blockers in Acute Myocardial Infarction Patients with Acute Kidney Injury.
Kim KA; Lee JE; Choi IJ; Lee KY; Kim CJ; Park MW; Park CS; Kim HY; Yoo KD; Jeon DS; Jeong MH; Chang K
Cardiorenal Med; 2024; 14(1):178-190. PubMed ID: 38471483
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Early SGLT2 Inhibitors Initiation in Diabetic Patients Following Acute Myocardial Infarction, a Retrospective Study.
Moady G; Yakubovich I; Atar S
J Cardiovasc Pharmacol Ther; 2024; 29():10742484241252474. PubMed ID: 38711298
[TBL] [Abstract][Full Text] [Related]
18. Contrast-Induced Acute Kidney Injury in Patients on SGLT2 Inhibitors Undergoing Percutaneous Coronary Interventions: A Propensity-Matched Analysis.
Hua R; Ding N; Guo H; Wu Y; Yuan Z; Li T
Front Cardiovasc Med; 2022; 9():918167. PubMed ID: 35795364
[TBL] [Abstract][Full Text] [Related]
19. Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study.
Chang TY; Lu CT; Huang HL; Chou RH; Chang CC; Liu CT; Huang PH; Lin SJ
Front Cardiovasc Med; 2022; 9():882181. PubMed ID: 35571176
[TBL] [Abstract][Full Text] [Related]
20. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.
Tsai TT; Patel UD; Chang TI; Kennedy KF; Masoudi FA; Matheny ME; Kosiborod M; Amin AP; Messenger JC; Rumsfeld JS; Spertus JA
JACC Cardiovasc Interv; 2014 Jan; 7(1):1-9. PubMed ID: 24456715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
